欧洲重症医学会临床实践指南:成人危重症患者液体治疗第三部分——降阶梯阶段的液体清除
该指南由欧洲重症医学会(ESICM)制定,聚焦成人危重症休克患者液体复苏急性期后的降阶梯阶段液体清除问题。专家组基于截至2025年2月发表的13项随机对照试验,采用GRADE方法学评估证据确定性并形成推荐。共发布三条条件性推荐:建议在液体复苏急性期后降阶梯液体治疗(低确定性证据);建议采用利尿剂方案化清除液体而非常规治疗(中等确定性证据);不常规推荐使用超滤或体外液体清除(低确定性证据)。特定患者队列的液体清除证据有限。
要点
- 休克液体复苏急性期后,建议降阶梯液体治疗而非不降阶梯(条件性推荐,低确定性证据)。
- 液体复苏急性期后,建议采用利尿剂方案化清除液体而非常规治疗(条件性推荐,中等确定性证据)。
- 无其他肾脏替代治疗指征时,不常规推荐使用超滤或体外液体清除(条件性推荐,低确定性证据)。
- 证据来源于13项随机对照试验,特定患者队列的液体清除证据有限。
- 指南适用于不再需要液体复苏的休克成人危重症患者。
适用人群与场景
- 成人危重症休克患者,处于液体复苏急性期后、不再需要液体复苏的降阶梯阶段。
处置流程与药物剂量
- 建议在液体复苏急性期后降阶梯液体治疗,而非不降阶梯(条件性推荐,低确定性证据)。
- 建议在液体复苏急性期后采用利尿剂方案化清除液体,而非常规治疗(条件性推荐,中等确定性证据)。
- 无其他肾脏替代治疗指征时,不常规推荐使用超滤或体外液体清除(条件性推荐,低确定性证据)。
研究设计与关键结果
- 指南基于截至2025年2月发表的13项随机对照试验数据,由国际专家组采用GRADE方法学制定,共发布三条条件性推荐。
- 证据确定性:降阶梯液体治疗为低确定性,利尿剂方案化液体清除为中等确定性,不常规使用超滤为低确定性。
- 特定患者队列的液体清除证据有限,专家组未能就此作出评论。
证据类型、等级与局限
- 证据类型:欧洲重症医学会(ESICM)临床实践指南,采用GRADE方法学评估证据确定性。
- 推荐强度:三条均为条件性推荐(conditional recommendations)。
- 证据确定性:降阶梯液体治疗为低确定性;利尿剂方案化液体清除为中等确定性;不常规使用超滤为低确定性。
- 局限:特定患者队列的液体清除证据有限。
对床旁实践的改变
- 该指南提示,在休克液体复苏急性期后、不再需要液体复苏的成人患者中,可考虑降阶梯液体治疗,并可采用利尿剂方案化清除液体;无其他肾脏替代治疗指征时,不常规推荐超滤或体外液体清除。
- 特定患者队列的液体清除证据有限,临床决策需结合个体情况。
指南或共识出处
- 欧洲重症医学会(ESICM)临床实践指南:成人危重症患者液体治疗第三部分——降阶梯阶段的液体清除。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: This is the third of three parts of the clinical practice guideline from the European Society of Intensive Care Medicine (ESICM) on fluid management in adult critically ill patients. This part addresses fluid removal in the de-escalation phase of shock management.
METHODS: This guideline was formulated by an international panel of clinical experts, methodologists, and patient representatives. A literature search was conducted to identify relevant randomized controlled trials (RCTs) in adults published up to February 2025. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology was applied to evaluate the certainty of evidence and to move from evidence to decision.
RESULTS: Based on data from 13 RCTs, the panel issued three conditional recommendations. The panel suggested de-escalation of fluid therapy over no de-escalation in critically ill adults after the acute phase of fluid resuscitation (low certainty evidence). They suggested protocolized fluid removal by diuretics over usual care in critically ill patients after the acute phase of fluid resuscitation (moderate certainty evidence). A conditional recommendation was issued against the routine use of ultrafiltration or extracorporeal fluid removal in critically ill adults after the acute phase of fluid resuscitation, without other indication for RRT (low certainty evidence). There was limited evidence to comment on fluid removal in specific patient cohorts.
CONCLUSIONS: This ESICM guideline provides three recommendations to inform clinicians on fluid removal during the de-escalation phase in critically ill patients with shock who no longer need fluid resuscitation.
参考来源
- Ostermann M, Alshamsi F, Artigas Raventos A, et al. European Society of Intensive Care Medicine Clinical Practice Guideline on fluid therapy in adult critically ill patients: Part 3-fluid removal at de-escalation phase. Intensive Care Med. 2025. PMID: 40828463. doi:10.1007/s00134-025-08058-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。